Refractory or intolerant to Mycosis Fungoides and sezary syndrome
Showing 9976 - 10000 of >10,000
Heart Failure, Heart Diseases, Cardiovascular Diseases Trial in Zabrze (treatment in day-care heart failure unit)
Unknown status
- Heart Failure
- +2 more
- treatment in day-care heart failure unit
-
Zabrze, Silesia, PolandSilesian Centre for Heart Disease
May 25, 2020
Chronic Kidney Diseases Trial in Lyon (impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients)
Not yet recruiting
- Chronic Kidney Diseases
- impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients
-
Lyon, FranceNephrology department, Hôpital Lyon Sud, Hospices Civils de Lyon
Jul 28, 2023
Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)
Recruiting
- Recurrent IDH1/2 Mutated Glioma
-
Paris, FrancePitie Salpetriere Hospital
Aug 29, 2022
Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
- Idiopathic CD4-Positive
- T-Lymphocytopenia
- Filgrastim
- Plerixafor
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Irritable Bowel Syndrome, Dyspepsia, Functional Constipation Trial in Rouen (Observational study)
Recruiting
- Irritable Bowel Syndrome
- +3 more
- Observational study
-
Rouen, FrancePhysiology Unit, Hopital Charles Nicolle, 1 rue de Germont
Jun 5, 2021
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
COVID-19 Trial in Spain (Convalescent anti-SARS-CoV-2 MBT Plasma, Standard Medical Treatment)
Completed
- COVID-19
- Convalescent anti-SARS-CoV-2 MBT Plasma
- Standard Medical Treatment
-
Alicante, Spain
- +11 more
Mar 2, 2021
Lymphoma, Relapsed and Refractory, DLBCL and Follicular Lymphoma Trial in New York (Mocetinostat)
Active, not recruiting
- Lymphoma
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 17, 2021
Hypotension, Critical Illness Trial in Boston, Nedlands (Midodrine, Placebo)
Bariatric Surgery, Weight Loss, Comorbidities and Coexisting Conditions Trial in Almelo (Placement of MiniMizer Gastric Ring,
Recruiting
- Bariatric Surgery
- +2 more
- Placement of MiniMizer Gastric Ring
- Normal MGB-OAGB
-
Almelo, NetherlandsZiekenhuisgroep Twente
Jul 20, 2022
B-ALL, DLBCL, B ALL Trial in New York (131-I Apamistamab, CAR T-cell)
Recruiting
- B-ALL
- +10 more
- 131-I Apamistamab
- CAR T-cell
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 7, 2022
Hemophagocytic Syndrome (HPS) Trial in Ann Arbor (Ruxolitinib)
Completed
- Hemophagocytic Syndrome (HPS)
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Jan 4, 2021
Acute Lymphoblastic Leukemia, Non-hodgkin Lymphoma,B Cell Trial in Hangzhou (Humanized CD19 CAR-T cells)
Recruiting
- Acute Lymphoblastic Leukemia
- Non-hodgkin Lymphoma,B Cell
- Humanized CD19 CAR-T cells
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,College of Medicine, Zhejiang Univ
Aug 25, 2020
Primary CNS Lymphoma, Secondary CNS Lymphoma Trial (F520)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
- (no location specified)
Oct 19, 2020
Food Insecurity, Obesity, Childhood, Inflammation Trial (Food Secure Group)
Not yet recruiting
- Food Insecurity
- +3 more
- Food Secure Group
- (no location specified)
Jul 8, 2021
Leukemia Trial in New York (therapeutic autologous lymphocytes, cyclophosphamide)
Active, not recruiting
- Leukemia
- therapeutic autologous lymphocytes
- cyclophosphamide
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 18, 2021
Chronic Spontaneous Urticaria, Angioedema Trial in Germany (Omalizumab, Placebo)
Completed
- Chronic Spontaneous Urticaria
- Angioedema
- Omalizumab
- Placebo
-
Mannheim, Baden-Wuerttemberg, Germany
- +24 more
Aug 21, 2020
Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth Trial in Kuala Lumpur (Rifaximin, Low FODMAP diet)
Recruiting
- Irritable Bowel Syndrome
- Small Intestinal Bacterial Overgrowth
- Rifaximin
- Low FODMAP diet
-
Kuala Lumpur, MalaysiaUniversity Malaya Medical Centre
May 4, 2021
15q Duplication Syndrome, CDKL5 Deficiency Disease Trial in United States (Soticlestat)
Completed
- 15q Duplication Syndrome
- CDKL5 Deficiency Disease
-
Los Angeles, California
- +7 more
May 24, 2022
Fibromyalgia Trial in Almeria (Manipulative and Massage Therapy, Exercise Program)
Active, not recruiting
- Fibromyalgia
- Manipulative and Massage Therapy
- Exercise Program
-
Almeria, SpainAdelaida María Castro-Sánchez
Nov 11, 2020
Genetic Regulation of Surfactant Deficiency
Completed
- Respiratory Distress Syndrome, Newborn
-
Saint Louis, MissouriSt. Louis Children's Hospital
Jun 4, 2021
Sudden Infant Death Syndrome (SIDS) Trial in Cincinnati (Children's Book, Standard Brochures)
Completed
- Sudden Infant Death Syndrome (SIDS)
- Children's Book
- Standard Brochures
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 5, 2021